Decentralized Trial Technology Resources
-
EDC For Mid-Study Changes In Medical Device Clinical Trials
6/21/2022
In this case study, discover how a company was pointed to an electronic data capture (EDC) system that was quick to adapt and easy to scale as the study changed.
-
The Win-Win Wth Virtual Visits – Better Experiences, Better Data
2/29/2024
Discover how researchers can design studies with the needs of the patient in mind to promote faster enrollment, high engagement, and the production of more complete and accurate data.
-
Bring Your Own Device (BYOD) Clinical Trials
4/8/2025
Bring Your Own Device (BYOD) is revolutionizing clinical trials by enabling participants and researchers to use their own smartphones, tablets, or computers to collect and manage data.
-
Navigating Wearable Integration: Key Operational Considerations
4/5/2024
Explore wearable devices' transformative potential and innovative capabilities for data collection, patient monitoring, and endpoint measurement.
-
Effective Use Of IRT In Decentralized And Hybrid Clinical Trials
1/5/2023
Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.
-
Increase Participant Diversity With eClinical Tools
4/14/2023
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
The Future Of Clinical Trials Rests On A Unified CTMS Platform
8/1/2022
Discover why a unified CTMS platform is the answer for managing both the clinical trial itself and the data it produces when it comes to poorly integrated clinical trial management systems (CTMS).
-
How eCOA Improves Patient Experience
8/10/2022
Explore how to ensure that clinical trials are truly patient-centered, and why it is critical to do so.
-
4 Ways Home Visits Support Successful Rare Disease Clinical Trials
4/25/2023
Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.
-
5 Essential Capabilities For Decentralized Clinical Trials
2/3/2025
Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.